📈 Sunshine Holdings Posts 16.6% YoY Revenue Growth in 1QFY27

• Overall Financials: Diversified conglomerate Sunshine Holdings PLC achieved consolidated revenue of LKR 18.5 Bn (+16.6% YoY) in 1QFY27, boosted by portfolio diversification and JAPC consolidation. Gross profit rose 3.2% YoY to LKR 5.2 Bn, while profit after tax climbed 6.0% YoY to LKR 1.4 Bn despite regulatory pricing and margin pressures. • Healthcare: Remained the largest top-line driver (49.2% of total revenue) at LKR 9.1 Bn (+5.9% YoY). Strong gains in medical devices (+8.8% YoY) and pharma manufacturing via Lina Manufacturing (+20.5% YoY) offset NMRA-driven price caps and an 18.2% contraction in the pharma agency segment. Strategic push includes founding Zydus Sunshine Lifesciences to bolster national pharmaceutical manufacturing. • Consumer Sector: Soared 38.0% YoY to LKR 6.6 Bn (35.6% of group revenue), largely propelled by JAPC's consolidation. Excluding JAPC, organic growth rose 2.1% YoY, anchored by resilience in branded tea (+8.3% YoY via Watawala Thei and Ran Kahata) and confectionery (+6.9% YoY). JAPC's spice exports grew 11.5% YoY, though tea export revenue dipped 6.3% YoY. • Agribusiness: Watawala Plantations PLC delivered revenue of LKR 2.8 Bn (+12.7% YoY). Performance was driven by oil palm surging 17.9% YoY to LKR 2.5 Bn on better yields and prices, while dairy revenue fell 7.1% YoY to LKR 258.9 Mn due to higher input costs.